Lucrin Depot 3,75 mg Mikrosfery do sporządzania zawiesiny do wstrzykiwań Ba Lan - Tiếng Ba Lan - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

lucrin depot 3,75 mg mikrosfery do sporządzania zawiesiny do wstrzykiwań

abbvie polska sp. z o.o. - leuprorelini acetas - mikrosfery do sporządzania zawiesiny do wstrzykiwań - 3,75 mg

Finanorm 5 mg tabletki powlekane Ba Lan - Tiếng Ba Lan - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

finanorm 5 mg tabletki powlekane

pharmaswiss ceska republika s.r.o. - silica colloidalis anhydrica; finasteridum - tabletki powlekane - 5 mg

Propecia 1 mg Tabletki powlekane Ba Lan - Tiếng Ba Lan - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

propecia 1 mg tabletki powlekane

organon polska sp. z o.o. - finasteridum - tabletki powlekane - 1 mg

Finapil 1 mg Tabletki powlekane Ba Lan - Tiếng Ba Lan - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

finapil 1 mg tabletki powlekane

sun-farm sp. z o.o. - finasteridum - tabletki powlekane - 1 mg

Stymen 10 mg Tabletki Ba Lan - Tiếng Ba Lan - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

stymen 10 mg tabletki

aflofarm farmacja polska sp. z o.o. - dehydroepiandrosteronum - tabletki - 10 mg

Firmagon Liên Minh Châu Âu - Tiếng Ba Lan - EMA (European Medicines Agency)

firmagon

ferring pharmaceuticals a/s - degareliks - nowotwory stercza - terapia endokrynologiczna - firmagon is a gonadotrophin releasing hormone (gnrh) antagonist indicated:- for treatment of adult male patients with advanced hormone-dependent prostate cancer. - for treatment of high-risk localised and locally advanced hormone dependent prostate cancer in combination with radiotherapy. - as neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced hormone dependent prostate cancer.

Abiraterone Accord Liên Minh Châu Âu - Tiếng Ba Lan - EMA (European Medicines Agency)

abiraterone accord

accord healthcare s.l.u. - octan abirateronu - nowotwory stercza - terapia endokrynologiczna - abiraterone accord is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicatedthe treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abiraterone Mylan Liên Minh Châu Âu - Tiếng Ba Lan - EMA (European Medicines Agency)

abiraterone mylan

mylan ireland limited - octan abirateronu - nowotwory stercza - endocrine therapy, other hormone antagonists and related agents - abiraterone mylan is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt). the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated. the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel based chemotherapy regimen.

Abiraterone Krka Liên Minh Châu Âu - Tiếng Ba Lan - EMA (European Medicines Agency)

abiraterone krka

krka, d.d., novo mesto - octan abirateronu - nowotwory stercza - terapia endokrynologiczna - abiraterone krka is indicated with prednisone or prednisolone for:the treatment of newly diagnosed high risk metastatic hormone sensitive prostate cancer (mhspc) in adult men in combination with androgen deprivation therapy (adt) (see section 5. 1)the treatment of metastatic castration resistant prostate cancer (mcrpc) in adult men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. 1)the treatment of mcrpc in adult men whose disease has progressed on or after a docetaxel-based chemotherapy regimen.

Diphereline SR 11,25 mg 11,25 mg Proszek i rozpuszczalnik do sporządzania zawiesiny o przedłużonym uwalnianiu do wstrzykiwań Ba Lan - Tiếng Ba Lan - URPL (Urząd Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych)

diphereline sr 11,25 mg 11,25 mg proszek i rozpuszczalnik do sporządzania zawiesiny o przedłużonym uwalnianiu do wstrzykiwań

ipsen pharma - triptorelini pamoas - proszek i rozpuszczalnik do sporządzania zawiesiny o przedłużonym uwalnianiu do wstrzykiwań - 11,25 mg